Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces

Fairé, R.; van Malenstein, H.; De Vos, A.; Geboes, K.; Depoortere, I.; Vanden Berghe, P.; Fornari, F.; Blondeau, K.; Mertens, V.; Tack, J.; Sifrim, D.
October 2008
Gut;Oct2008, Vol. 57 Issue 10, p1366
Academic Journal
Background: Severe duodeno-gastro-oesophageal reflux (ODOR) is a risk factor for oesophagitis and Barrett's oesophagus. Patients with non-erosive reflux disease (NERD) have a slight increase in DOOR. Patients with gastro-oesophageal reflux disease (GORD), who are taking proton pump inhibitors (PPIs), still have reflux but of weakly acidic pH and persistence of bile. In these two groups of patients, heartburn might be due to increased oesophageal mucosal permeability and dilated intercellular spaces (DIS). We aimed to assess whether experimental short exposure of the oesophageal mucosa to bile acids, in low concentrations (at acidic, weakly acidic and neutral conditions) can increase mucosal permeability and provoke DIS. Methods: Rabbit oesophageal mucosa was studied in diffusion and Ussing chambers. We assessed the effects of different solutions containing bile acids, applied to the mucosal side, on transepithelial electrical resistance (RT) and permeability to fluorescein. The diameter of intercellular spaces was assessed by using transmission electron microscopy. Results: Incubation of oesophageal mucosa with acidic solutions (pH 2.0) containing a range of bile acids (0.5-5 mmol/l) markedly decreased RT and increased mucosal permeability. Weakly acidic solutions (pH 5.0), and to some extent neutral solutions (pH 7.4), containing some bile acids also decreased RT and increased permeability, although the effects were much less marked and in some combinations no effect was seen. Exposure to bile acids provoked DIS in acid and weakly acidic conditions but not in neutral (pH 7.4) solutions. Conclusions: Experimental short exposure of the oesophageal mucosa to solutions with a bile acid concentration and acidity similar to that observed in the gastric contents of patients with NERD or ERD, and who are taking PPIs, may impair oesophageal mucosal integrity and even induce dilated intercellular spaces. Such a situation could, theoretically, underlie the occurrence and! or persistence of symptoms in these patients.


Related Articles

  • Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors. Monaco, Luigi; Brillantino, Antonio; Torelli, Francesco; Schettino, Michele; Izzo, Giuseppe; Cosenza, Angelo; Di Martino, Natale; Shimatani, Tomohiko // World Journal of Gastroenterology;1/21/2009, Vol. 15 Issue 3, p334 

    AIM: To determine the prevalence and characteristics of bile reflux in gastroesophageal reflux disease (GERD) patients with persistent symptoms who are non-responsive to medical therapy. METHODS: Sixty-five patients (40 male, 25 female; mean age, 50 ± 7.8 years) who continued to report...

  • Prevention of Barrett's metaplasia in a human model of duodenogastro-oesophageal reflux. Cade, Richard J.; Fox, Adrian M.; Fahy, Eamonn T.; Hii, Michael W. // Gastroenterology Insights;2013, Vol. 5 Issue 1, p12 

    The development of Barrett's esophagus above the anastomosis following esophagogastrectomy has been reported in several studies. In this prospective study we set out to examine the prevalence of this phenomenon in a group of patients who have been strictly adherent to post operative proton pump...

  • Proton Pump Inhibitors: Effective First-Line Treatment for Management of Dyspepsia. David Peura; Jeff Gudmundson; Nancy Siepman; Betsy Pilmer; James Freston // Digestive Diseases & Sciences;Apr2007, Vol. 52 Issue 4, p983 

    Abstract  The aim of this study was to evaluate the reasons for trial exclusion among dyspeptic patients and estimate the proportion that may have benefited from proton pump inhibitor (PPI) therapy. Stringent inclusion criteria for enrollment in two multicenter functional dyspepsia trials...

  • A Cost-Effectiveness Analysis of Prescribing Strategies in the Management of Gastroesophageal Reflux Disease. Gerson, Lauren B.; Robbins, Anthony S.; Garber, Alan; Hornberger, John; Triadafilopoulos, George // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p395 

    OBJECTIVE: Patients who have uncomplicated gastroesophageal- reflux disease (GERD) typically present with heartburn and acid regurgitation. We sought to determine the cost-effectiveness of H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) as first-line empiric therapy for...

  • Pilot Study of On-Demand Therapy with Pantoprazole 20mg for Long-Term Treatment in Patients with Mild Gastro-Oesophageal Reflux Disease. Scholten, Theo; Pustlauk, Uwe; Sander, Peter; Bohuschke, Martina; Gatz, Gudrun // Clinical Drug Investigation;2005, Vol. 25 Issue 10, p633 

    Background: Few clinical studies have demonstrated the efficacy of proton pump inhibitors (PPIs) as on-demand therapy for the long-term management of patients with mild gastro-oesophageal reflux disease (GORD). On-demand therapy with pantoprazole 20mg may offer an effective strategy for the...

  • Editorial: Bringing GERD Management up to PAR-2. Souza, Rhonda F. // American Journal of Gastroenterology;Sep2010, Vol. 105 Issue 9, p1944 

    Proton pump inhibitors (PPIs) are extremely effective for mucosal healing of reflux esophagitis, but less so for relieving the symptom of heartburn. PPIs block the secretion of gastric acid, the caustic effects of which have been assumed to be the primary culprit in the pathogenesis of reflux...

  • Got GERD? Dietary Changes Can Ease the Burn.  // Women's Nutrition Connection;Mar2016, Vol. 19 Issue 3, p1 

    The article discusses some dietary changes that can be adopted by people with gastroesophageal reflux disease (GERD) or frequent heartburn to eliminate the need for proton pump inhibitors (PPI) medications. It cites other symptoms of GERD, foods and beverages that increase gastric secretions and...

  • Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease: An Observational, Multicentre Study. Hoogendoorn, Robert J.; Groeneveld, Lex; Kwee, J. Andy // Clinical Drug Investigation;2009, Vol. 29 Issue 12, p803 

    Objective: To determine treatment satisfaction in patients with gastrooesophageal reflux disease (GORD) when switched to esomeprazole. Methods: This observational, multicentre study conducted in the Netherlands included primary-care patients being treated with a proton pump inhibitor (PPI)...

  • Current Understanding of the Mechanisms of Gastro-oesophageal Reflux Disease. Orlando, Roy C. // Drugs;2006 Supplement 1, Vol. 66, p1 

    Gastro-oesophageal reflux disease (GERD) covers a broad range of signs and symptoms arising from the orad movement of gastric contents into the oesophagus, oropharynx, larynx or airway. Most commonly, contact with and damage to the oesophageal epithelium by acidic refluxate causes micro or...


Read the Article


Sign out of this library

Other Topics